Galectin Therapeutics Inc. (GALT) shares outstanding

Shares outstanding · fiscal 2025
63.90M

Galectin Therapeutics Inc. (GALT) had 63.90M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 2.6% higher than the 62.31M of fiscal 2024. Figures as of 18 Nov 2026, 12:17 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Shares outstanding, fiscal 2025
63.90M
Change on fiscal 2024
+2.6%
Growth, 5 years
+2.3% a year
Highest on record
63.90Mfiscal 2025
Lowest on record
57.03Mfiscal 2020
Fiscal years on record
62020–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Galectin Therapeutics Inc. shares outstanding, in more detail

The market data feed counts 100.85M shares outstanding today.

Over the five fiscal years to 2025 the diluted share count grew at a compound 2.3% a year. Across the 6 fiscal years on record (2020–2025), the highest was 63.90M in fiscal 2025 and the lowest 57.03M in fiscal 2020.

History · 6 fiscal years

Shares outstanding by fiscal year

Galectin Therapeutics Inc. shares outstanding, year by year

Galectin Therapeutics Inc. (GALT) shares outstanding by fiscal year
Fiscal yearShares outstandingChangeYear ended
202563.90M 2.6% up
202462.31M 3.6% up
202360.16M 1.3% up
202259.39M 1.5% up
202158.53M 2.6% up
202057.03M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed.

How to read it

A falling count means buybacks are giving each remaining share a larger slice of the company; a rising one means owners are being diluted.

More on GALT

Galectin Therapeutics Inc., figure by figure

Galectin Therapeutics Inc. (GALT) overview: price, valuation and scorecard

Galectin Therapeutics Inc. shares outstanding: questions and answers

How many shares does Galectin Therapeutics Inc. have?

Galectin Therapeutics Inc. (GALT) had 63.90M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 2.6% higher than the 62.31M of fiscal 2024. The market data feed counts 100.85M shares outstanding today.

What is the growth rate of Galectin Therapeutics Inc.'s diluted share count?

Over the five fiscal years to 2025 the diluted share count grew at a compound 2.3% a year.

What are the highest and lowest diluted share count figures on record for Galectin Therapeutics Inc.?

Across the 6 fiscal years on record (2020–2025), the highest was 63.90M in fiscal 2025 and the lowest 57.03M in fiscal 2020.

How is Galectin Therapeutics Inc.'s diluted share count calculated?

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed. For Galectin Therapeutics Inc. it is on record here for 6 fiscal years, 2020 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Galectin Therapeutics Inc. (GALT) shares outstanding”, data as of 18 November 2026. https://funkfolio.com/stock/GALT/shares-outstanding

Underlying data: the company's filings with the SEC and Yahoo Finance.